Ascott Residence Trust – Moats on all sides July 29, 2021 566

PSR Recommendation: ACCUMULATE Status: Maintained
Target Price: 1.190
  • 1H21 DPU up 95% YoY to 2.05 cents, in line at 47% of our estimate.
  • Gradual recovery evident from rising RevPAU, occupancy and better bookings. Redeploying divestment proceeds to higher-yielding investments in extended-stay segment to improve earnings stability and replace divested EBITDA.
  • Maintain ACCUMULATE. DDM-based (COE 8.5%) TP raised from S$1.17 to S$1.19. We raise FY21e/22e DPUs by 0.7%/1.2% to capture acquisition of two Sapporo rental housing assets in June. FY23e/24e DPUs raised by 1.8%/2.3% for 45% stake in student accommodation development. ART remains our top pick in the sector. Catalysts include acquisitions and asset recycling. That said, recovery timeline may be more protracted if the virus mutates or there are fresh waves.

 

 

 

The Positives

  • Gradual recovery in operations. This was ART’s fourth quarter of RevPAU recovery (Figure 1), led by higher occupancy. 2Q21 RevPAU grew 18% QoQ and 75% YoY. Portfolio occupancy climbed from 50% in 1Q20 to 55% (4Q20: 45%). Recall that 12 properties were closed in 1Q21 due to muted demand. ART reopened eight in May/June and two in July following higher demand. Two properties in Japan remained close but ART continued to receive minimum rent from their master lessees. 1H21 gross profits in China and Australia were up 4% and 103% YoY, supported by higher corporate demand and improvements in their COVID-19 situation. Portfolio also benefitted from block bookings in Australia, Singapore and the US, while two properties in Japan secured group bookings from media groups for the Olympics. Forward bookings have also improved with more corporate and relocation enquiries in the US and Singapore.
  • Cost savings. 1H21 revenue was down 11% due to an absence of income from divested assets (-S$13mn), changes in rental structures and the full impact of COVID-19, compared to 1H20 when lockdowns started in February/March 2020. Lower revenue was partially compensated by its acquisition of Paloma West Midtown which contributed S$2mn from 27 February 2021. Digitalisation also reduced man hours and staff costs, resulting in a smaller 7% decline in gross profits. On a same-store basis, revenue and gross profit were down a lesser 8% and 1% respectively.
  • Shoring up stable revenue with divestment proceeds. ART has divested six properties since 2020 for S$580mn in proceeds and S$225mn in net gains. Exit yields for these averaged 2%. It has reinvested S$285mn in five long-stay student accommodation and rental housing assets, with an average EBITDA yield of 5%. Four are currently operational and should contribute S$9mn to full-year EBITDA. This will help replace 77.6% of its divested EBITDA. ART’s most recent investment was a 45% stake in a student accommodation in South Carolina, US. The remaining 45%/10% stakes will be held by sponsor Ascott Limited (not listed) and an unnamed US student-housing developer. Construction is scheduled to start in 3Q21 and complete in 2Q23. Development cost is S$146.2mn and EBITDA yield, estimated at 6.2%. The yield is about 120bp higher than its first student accommodation asset, Paloma West Midtown. The latter is a stabilised asset and was acquired on 27 February 2021 at an EBITDA yield of 5%.

 

The Negative

  • Booked S$5.3mn provisions for Park Hotel. ART is in the process of repossessing Park Hotel Clarke Quay after its master lessee failed to make rent payments. On 18 June, it served a letter of demand for the outstanding S$5.9mn after netting off a S$6.8mn security deposit to the guarantor, Park Hotel Management Pte Ltd. Park Hotel Management is currently undergoing liquidation. Park Hotel Clarke Quay has been block-booked by the Singapore government since May 2021 and is expected to be cashflow-positive. ART’s sponsor has been engaged to manage the property while ART assesses its options. Options include bringing in a new master lessee, rebranding under a new hotel operator or divestment. The asset is well-located in Clarke Quay and is expected to benefit from the reopening of international borders as well as a redeveloped Liang Court in 2025. ART is working with liquidators to recover its debt.

Important Information

This report is prepared and/or distributed by Phillip Securities Research Pte Ltd ("Phillip Securities Research"), which is a holder of a financial adviser’s licence under the Financial Advisers Act, Chapter 110 in Singapore.

By receiving or reading this report, you agree to be bound by the terms and limitations set out below. Any failure to comply with these terms and limitations may constitute a violation of law. This report has been provided to you for personal use only and shall not be reproduced, distributed or published by you in whole or in part, for any purpose. If you have received this report by mistake, please delete or destroy it, and notify the sender immediately.

The information and any analysis, forecasts, projections, expectations and opinions (collectively, the “Research”) contained in this report has been obtained from public sources which Phillip Securities Research believes to be reliable. However, Phillip Securities Research does not make any representation or warranty, express or implied that such information or Research is accurate, complete or appropriate or should be relied upon as such. Any such information or Research contained in this report is subject to change, and Phillip Securities Research shall not have any responsibility to maintain or update the information or Research made available or to supply any corrections, updates or releases in connection therewith.

Any opinions, forecasts, assumptions, estimates, valuations and prices contained in this report are as of the date indicated and are subject to change at any time without prior notice. Past performance of any product referred to in this report is not indicative of future results.

This report does not constitute, and should not be used as a substitute for, tax, legal or investment advice. This report should not be relied upon exclusively or as authoritative, without further being subject to the recipient’s own independent verification and exercise of judgment. The fact that this report has been made available constitutes neither a recommendation to enter into a particular transaction, nor a representation that any product described in this report is suitable or appropriate for the recipient. Recipients should be aware that many of the products, which may be described in this report involve significant risks and may not be suitable for all investors, and that any decision to enter into transactions involving such products should not be made, unless all such risks are understood and an independent determination has been made that such transactions would be appropriate. Any discussion of the risks contained herein with respect to any product should not be considered to be a disclosure of all risks or a complete discussion of such risks.

Nothing in this report shall be construed to be an offer or solicitation for the purchase or sale of any product. Any decision to purchase any product mentioned in this report should take into account existing public information, including any registered prospectus in respect of such product.

Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may provide an array of financial services to a large number of corporations in Singapore and worldwide, including but not limited to commercial / investment banking activities (including sponsorship, financial advisory or underwriting activities), brokerage or securities trading activities. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have participated in or invested in transactions with the issuer(s) of the securities mentioned in this report, and may have performed services for or solicited business from such issuers. Additionally, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may have provided advice or investment services to such companies and investments or related investments, as may be mentioned in this report.

Phillip Securities Research or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report may, from time to time maintain a long or short position in securities referred to herein, or in related futures or options, purchase or sell, make a market in, or engage in any other transaction involving such securities, and earn brokerage or other compensation in respect of the foregoing. Investments will be denominated in various currencies including US dollars and Euro and thus will be subject to any fluctuation in exchange rates between US dollars and Euro or foreign currencies and the currency of your own jurisdiction. Such fluctuations may have an adverse effect on the value, price or income return of the investment.

To the extent permitted by law, Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may at any time engage in any of the above activities as set out above or otherwise hold an interest, whether material or not, in respect of companies and investments or related investments, which may be mentioned in this report. Accordingly, information may be available to Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, which is not reflected in this report, and Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited to its officers, directors, employees or persons involved in the issuance of this report, may, to the extent permitted by law, have acted upon or used the information prior to or immediately following its publication. Phillip Securities Research, or persons associated with or connected to Phillip Securities Research, including but not limited its officers, directors, employees or persons involved in the issuance of this report, may have issued other material that is inconsistent with, or reach different conclusions from, the contents of this report.

The information, tools and material presented herein are not directed, intended for distribution to or use by, any person or entity in any jurisdiction or country where such distribution, publication, availability or use would be contrary to the applicable law or regulation or which would subject Phillip Securities Research to any registration or licensing or other requirement, or penalty for contravention of such requirements within such jurisdiction.

This report is intended for general circulation only and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. The products mentioned in this report may not be suitable for all investors and a person receiving or reading this report should seek advice from a professional and financial adviser regarding the legal, business, financial, tax and other aspects including the suitability of such products, taking into account the specific investment objectives, financial situation or particular needs of that person, before making a commitment to invest in any of such products.

This report is not intended for distribution, publication to or use by any person in any jurisdiction outside of Singapore or any other jurisdiction as Phillip Securities Research may determine in its absolute discretion.

IMPORTANT DISCLOSURES FOR INCLUDED RESEARCH ANALYSES OR REPORTS OF FOREIGN RESEARCH HOUSE

Where the report contains research analyses or reports from a foreign research house, please note:

  1. recipients of the analyses or reports are to contact Phillip Securities Research (and not the relevant foreign research house) in Singapore at 250 North Bridge Road, #06-00 Raffles City Tower, Singapore 179101, telephone number +65 6533 6001, in respect of any matters arising from, or in connection with, the analyses or reports; and
  2. to the extent that the analyses or reports are delivered to and intended to be received by any person in Singapore who is not an accredited investor, expert investor or institutional investor, Phillip Securities Research accepts legal responsibility for the contents of the analyses or reports.
Subscribe
Notify of
guest
0 Comments
Inline Feedbacks
View all comments

Get access to all the latest market news, reports, technical analysis
by signing up for a free account today!